A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
Clinical trial NCT00583830 · COMPLETED
Trial details
- NCT number
- NCT00583830
- Sponsor
- Human Genome Sciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2010-11-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.